Sabine C A Meijvis
Overview
Explore the profile of Sabine C A Meijvis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Colombijn J, Idema D, van Beem S, Blokland A, van der Braak K, Handoko M, et al.
JAMA Netw Open
. 2024 Mar;
7(3):e240427.
PMID: 38451526
Importance: Patients with chronic kidney disease (CKD) are at high risk for cardiovascular disease, but their systematic underrepresentation in cardiovascular randomized clinical trials (RCTs) limits the generation of appropriate evidence...
2.
Colombijn J, Idema D, van der Braak K, Spijker R, Meijvis S, Bots M, et al.
Syst Rev
. 2022 Nov;
11(1):238.
PMID: 36371302
Background: Patients with chronic kidney disease (CKD) require a personalised strategy for cardiovascular risk management (CVRM) to reduce their high risk of cardiovascular morbidity and mortality. Despite their high risk,...
3.
van Roeden S, van Oevelen M, Abrahams A, Dekker F, Rotmans J, Meijvis S
BMC Nephrol
. 2021 Sep;
22(1):308.
PMID: 34517829
Introduction: To prevent infection and thrombosis of central venous catheters (CVCs) in hemodialysis patients, different CVC lock solutions are available. Taurolidine-based solutions and citrate in different concentrations are frequently used,...
4.
Vestjens S, Spoorenberg S, Rijkers G, Grutters J, van de Garde E, Meijvis S, et al.
Eur Respir J
. 2015 May;
46(2):570-3.
PMID: 26022953
No abstract available.
5.
Spoorenberg S, Meijvis S, Navis G, Bos W
NDT Plus
. 2015 May;
4(5):365-6.
PMID: 25984195
No abstract available.
6.
Elberse K, van Mens S, Cremers A, Meijvis S, Vlaminckx B, de Jonge M, et al.
BMC Infect Dis
. 2015 Apr;
15:56.
PMID: 25885896
Background: Treatment of community acquired pneumonia (CAP) patients with antibiotics before laboratory-confirmed diagnosis leads to loss of knowledge on the causative bacterial pathogen. Therefore, an increasing number of pneumococcal infections...
7.
Spoorenberg S, Meijvis S, Navis G, Ruven H, Biesma D, Grutters J, et al.
Nephron Clin Pract
. 2013 Apr;
122(3-4):67-74.
PMID: 23594728
Background/aims: The presence of baseline proteinuria predicts the outcome in patients with chronic kidney disease and in the general population, independent of renal function. However, the predictive value of proteinuria...
8.
Remmelts H, van de Garde E, Meijvis S, Peelen E, Damoiseaux J, Grutters J, et al.
Clin Infect Dis
. 2012 Sep;
55(11):1488-94.
PMID: 22942205
Background: Vitamin D plays a role in host defense against infection. Vitamin D deficiency is common worldwide. The prognostic value of vitamin D levels in pneumonia is unknown. In this...
9.
Remmelts H, Meijvis S, Biesma D, van Velzen-Blad H, Voorn G, Grutters J, et al.
Clin Vaccine Immunol
. 2012 Aug;
19(9):1532-8.
PMID: 22855392
The influence of adjunctive corticosteroids on the cytokine response in community-acquired pneumonia (CAP) is largely unknown. In this study, we analyzed the effect of dexamethasone on the cytokine response in...
10.
Remmelts H, Meijvis S, Heijligenberg R, Rijkers G, Oosterheert J, Bos W, et al.
J Infect
. 2012 Mar;
65(1):25-31.
PMID: 22410382
Objectives: Adjuvant dexamethasone treatment in patients with community-acquired pneumonia (CAP) can reduce length of hospital stay. Whether there are subgroups of patients that especially might benefit from corticosteroids is unknown....